We recently published a list of 10 Stocks Lead Monday’s Charge Amid Market Bloodbath. In this article, we are going to take a ...
British consumer healthcare group Haleon on Thursday said 2025 revenue and profit growth would be weighted to the second half ...
Haleon CEO Brian McNamara says his company is not as exposed as peers to tariff risks, as the consumer healthcare company ...
Shares of Haleon PLC HLN rallied 4.18% to £3.98 Friday, on what proved to be an all-around favorable trading session for the ...
Haleon PLC HLN shares slipped 3.31% to £3.82 Thursday, on what proved to be an all-around favorable trading session for the ...
Berenberg analyst Bethan Davies raised the firm’s price target on Haleon (HLN) to 457 GBp from 456 GBp and keeps a Buy rating on the ...
The maker of Panadol, Sensodyne toothpaste and Centrum vitamins posted a higher pretax profit for 2024 despite lower revenue.
Deutsche Bank raised the firm’s price target on Haleon (HLN) to 390 GBp from 375 GBp and keeps a Hold rating on the shares.Discover the Best ...
Learn more about whether Haleon plc or Intra-Cellular Therapies, Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.
Haleon posted £11.23B in FY24 revenue, with 5% organic growth. 2025 guidance expects 4-6% organic growth, with profit gains ...
Allergy care brand Piri has added Pirilieve Hayfever Relief Tablets containing fexofenadine hydrochloride – an active ...
We recently compiled a list of the 12 Best Low Price Pharma Stocks To Invest In Right Now. In this article, we are going to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results